We are excited to announce that we are now accepting applications for our next TREAT-NMD Advisory Committee for Therapeutics (TACT) meetings.
There is one spot available for our upcoming Virtual Meeting in July, 2025 and three spots available for our Autumn meeting which will take place in Atlanta on the 7th – 9th of November 2025. This is a unique opportunity gain insights from TACT, an exclusive panel of international experts in neuromuscular diseases.
What is TACT?
The TREAT-NMD Advisory Committee for Therapeutics (TACT) is a unique, multi-disciplinary group of international experts. TACT brings together academic and industry drug development specialists, representatives from patient foundations, and regulatory bodies, all working together to evaluate the drug/therapy development programmes targeting neuromuscular diseases.
TACT’s mission is to apply a multi disciplinary group of key opinion leaders who can provide guidance on how to optimise drug design and development. The committee offers a comprehensive, confidential review process, providing constructive feedback to improve drug development programs.
Why Should You Apply?
- Multidisciplinary Expertise: Panels consist of experts across diverse fields tailored to your needs.
- Bespoke Panels: Each panel is assembled based on the specific questions and challenges you present.
- Independent and Unbiased: Reviewers are not paid by the applicant, ensuring impartial advice
- Broad Scope: The advice covers scientific, regulatory, clinical, and other relevant areas.
Details:
- Date: July 29th, 2025
- Location: Virtual Meeting
- Remaining Spots: 1
- Date: November 7th-9th, 2025
- Location: Atlanta, USA
- Remaining Spots: 3
Apply Now!
This is an excellent opportunity for those working in the field to engage with a diverse group of experts and help shape the future of neuromuscular disease therapies. But act quickly as spots get filled up fast. To find out more about how to apply: Email: info@treat-nmd.com. You can also find out more information on TACT, the panel and the process via the TACT section of our website
